Retail value sales of sleep aids are expected to remain negligible in Thailand in 2021. According to the FDA, sleep aids can be classified into two categories: Psychotropic drug (with psychotropic substance); and dangerous drug (may be dispensed by first-grade pharmacists). Sales to patients are only permitted with a doctor’s prescription.
The publisher's Sleep Aids in Thailand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.
Market sizes (historic and forecasts), company shares, brand shares and distribution data.
The publisher's Sleep Aids in Thailand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.
Data coverage:
Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Sleep Aids market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
2021 DEVELOPMENTSCONSUMER HEALTH IN THAILANDAPPENDIXDISCLAIMERDEFINITIONS
EXECUTIVE SUMMARY
MARKET INDICATORS
MARKET DATA
OTC registration and classification
SOURCES
